Meeting Banner
Abstract #3037

Assessment of R2* in Primary Colorectal Cancer: Reproducibility and Sequential Changes Following Chemoradiation in Relation to DCE-MRI Parameter Changes.

Vicky J. Goh1, N. Jane Taylor1, Aftab Khan, J James Stirling1, Ian C. Simcock1, Robert Kozarski2, Robert Glynne-Jones, James A. d'Arcy3, David J. Collins3, Anwar R. Padhani1

1Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, United Kingdom; 2University of Hertfordshire, Hatfield, Hertfordshire, United Kingdom; 3CRUK-EPSRC Cancer Imaging Centre, Institute of Cancer Research & Royal Marsden Hospital, Sutton, Surrey SM2 5PT, United Kingdom

The aim of this study was to assess the reproducibility of R2* and sequential changes following chemoradiation therapy (CRT), in relation to perfusion changes shown by dynamic contrast enhanced MRI (DCE-MRI). 14 patients underwent ISW-MRI and 3D DCE-MRI at 1.5T, pre- and up to 11 weeks post- chemoradiation. Cohort R2* increases post-CRT, corresponding to decreases in IAUGC60 and Ktrans. This, accompanied by loss of the baseline correlation between R2* and Ktrans suggests that colorectal tumors are made hypoxic by chemoradiotherapy. These results have implications with regard to the optimal timing of surgery following the completion of therapy.

Keywords

accompanied acquisition agreement allow approval assess assessed assessment background bland blood board bottom cancer coefficient cohort completion consent contrast correlated correlation correspondingly decreased decreases drawn dynamic enhanced experienced extended fractions hospital immediately implications informed institute institutional intrinsic just khan kingdom limits longitudinal loss made matched matrix model mount negatively onto optimal oxygenation parametric patient patients percentage perfusion post primary prior radiologist rank reducing regard relation repeatability repeated reproducibility respective respectively review royal scanner sequential series significance slice slices software statistics status subject successful suggest surgery surrey susceptibility tailed therapy timing trans transferred treatment tumors underwent usable variation volume weeks